Haisco Pharmaceutical Group

Perfil de la empresa

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Descripción disponible en inglés.

Datos societarios

Sector

Salud

Industria

Biotechnology

País

China

Sede

No. 17 Sanxiang Avenue, 856000, Shannan

Empleados

5.597

Cotización

002653 · SZSE

Divisa

CNY

Sitio web

haisco.com